• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

能力验证中表现不理想的原因。

Causes of unsatisfactory performance in proficiency testing.

作者信息

Jenny R W, Jackson-Tarentino K Y

机构信息

Laboratory for Molecular Diagnostics, Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Albany, NY 12201-0509, USA.

出版信息

Clin Chem. 2000 Jan;46(1):89-99.

PMID:10620576
Abstract

BACKGROUND

Proficiency testing (PT) provides a measure of the effectiveness of laboratory quality assurance programs. Test reports are released from processes that the laboratory judges to be in conformance with quality specifications; an evaluation of unsatisfactory performance (UNSAT) by a PT provider is an unexpected outcome for the laboratory. An understanding of the root cause(s) of testing errors provides an opportunity for the continuous improvement of laboratory services.

METHODS

We used participant data from the New York State Department of Health PT program to characterize the quality of testing in the toxicology specialty. Outcomes from laboratory investigations into causes of UNSAT and information on quality control practices collected from all program participants were used to identify the root causes of error.

RESULTS

Two classes of error were encountered: spurious test results caused by lapses in standard operating procedures and instrument malfunctions (300 per million assays) and common-cause analytic error (7000 per million assays or 0.7% rate of UNSAT). Causes of spurious results included inaccurate mathematical correction for specimen dilution, misinterpretation of instrument codes, and instrument sampling errors. Calibration drift was most frequently cited as the common-cause analytic error. Approximately one-half of the laboratories used an allowable error for the quality control of analytical systems that exceeded the threshold error specified by manufacturers for stable instrument performance.

CONCLUSIONS

The causes of spurious results suggest the need for ongoing competency testing of analysts where analyst intervention is required in an otherwise automated process, and for continued diligence in mistake-proofing instrument design. The intrinsic quality of laboratory testing is unlikely to improve until the allowable error in quality control is consistent with manufacturer specifications for stable system performance.

摘要

背景

能力验证(PT)可衡量实验室质量保证计划的有效性。测试报告由实验室判定符合质量规范的流程发布;PT提供者对不满意表现(UNSAT)的评估对实验室来说是意外结果。了解测试错误的根本原因可为实验室服务的持续改进提供契机。

方法

我们使用了纽约州卫生部PT计划的参与者数据来描述毒理学专业的测试质量。实验室对UNSAT原因的调查结果以及从所有计划参与者收集的质量控制实践信息用于确定错误的根本原因。

结果

遇到了两类错误:由标准操作程序失误和仪器故障导致的虚假测试结果(每百万次分析300次)以及常见原因分析错误(每百万次分析7000次或UNSAT率为0.7%)。虚假结果的原因包括标本稀释的数学校正不准确、仪器代码解读错误以及仪器采样错误。校准漂移最常被列为常见原因分析错误。约一半的实验室在分析系统质量控制中使用的允许误差超过了制造商规定的仪器稳定性能阈值误差。

结论

虚假结果的原因表明,在需要分析人员干预的自动化流程中,需要持续对分析人员进行能力测试,并且在仪器设计防错方面要持续保持严谨。在质量控制中的允许误差与制造商规定的系统稳定性能规范一致之前,实验室测试的内在质量不太可能提高。

相似文献

1
Causes of unsatisfactory performance in proficiency testing.能力验证中表现不理想的原因。
Clin Chem. 2000 Jan;46(1):89-99.
2
Evaluation of the rigor and appropriateness of CLIA '88 toxicology proficiency testing standards.对1988年临床实验室改进修正案(CLIA '88)毒理学能力验证测试标准的严谨性和适用性评估。
Clin Chem. 1992 Apr;38(4):496-500.
3
Utilizing global data to estimate analytical performance on the Sigma scale: A global comparative analysis of methods, instruments, and manufacturers through external quality assurance and proficiency testing programs.利用全球数据评估西格玛尺度下的分析性能:通过外部质量保证和能力验证计划对方法、仪器及制造商进行全球比较分析。
Clin Biochem. 2016 Jun;49(9):699-707. doi: 10.1016/j.clinbiochem.2016.02.013. Epub 2016 Mar 4.
4
Reasons for Proficiency Testing Failures in Routine Chemistry Analysis in China.中国常规化学分析中能力验证失败的原因。
Lab Med. 2019 Jan 1;50(1):103-110. doi: 10.1093/labmed/lmy032.
5
Proficiency testing of therapeutic drug monitoring techniques.治疗药物监测技术的能力验证
Clin Chem. 2000 Jan;46(1):132.
6
Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing.确保临床实验室改进修正案(CLIA)能力验证测试要求的质量所需的胆固醇操作过程规范。
Clin Chem. 1991 Nov;37(11):1938-44.
7
ASVCP guidelines: quality assurance for point-of-care testing in veterinary medicine.ASVCP指南:兽医学即时检验的质量保证
Vet Clin Pathol. 2013 Dec;42(4):405-23. doi: 10.1111/vcp.12099.
8
Performance characteristics of several rules for self-interpretation of proficiency testing data.几种能力验证数据自我解读规则的性能特征。
Arch Pathol Lab Med. 2005 Aug;129(8):997-1003. doi: 10.5858/2005-129-997-PCOSRF.
9
Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.抗逆转录病毒药物药代动力学检测的质量保证计划:2003年至2004年成人及儿科药理支持实验室的ACTG能力验证:治疗药物监测的一项要求
Ther Drug Monit. 2006 Jun;28(3):367-74. doi: 10.1097/01.ftd.0000211817.58052.b8.
10
Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.实验室精密性能:最新技术水平与确保临床实验室改进修正案能力验证所需分析质量的操作规范。
Arch Pathol Lab Med. 1996 Jul;120(7):621-5.

引用本文的文献

1
Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin.无抗体 LC-MS/MS 法检测 C 肽和胰岛素的实验室间比较
Clin Chem. 2024 Jun 3;70(6):855-864. doi: 10.1093/clinchem/hvae034.
2
Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II-Operations.液质联用技术在临床实验室中的应用评价:第二部分-操作。
Ann Lab Med. 2022 Sep 1;42(5):531-557. doi: 10.3343/alm.2022.42.5.531.
3
Sources of Variability and Accuracy of Performance Assessment in the Clinical Pharmacology Quality Assurance Proficiency Testing Program for Antiretrovirals.
抗逆转录病毒药物临床药理学质量保证能力验证计划中性能评估的变异性和准确性的来源。
Ther Drug Monit. 2019 Aug;41(4):452-458. doi: 10.1097/FTD.0000000000000612.
4
Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories.临床药理学质量保证计划:国际实验室抗逆转录病毒能力验证的纵向分析模型。
Ther Drug Monit. 2013 Oct;35(5):631-42. doi: 10.1097/FTD.0b013e31828f5088.
5
Quality leadership and quality control.质量领导力与质量控制。
Clin Biochem Rev. 2003 Aug;24(3):81-93.